The APOE polymorphism in Alzheimer's disease patients with neuropsychiatric symptoms and syndromes

International Journal of Geriatric Psychiatry

Volumn 26, Issue 10, 2011, Pages 1062-1070

  D'Onofrio, Grazia ^a   Panza, Francesco ^a   Seripa, Davide ^a   Sancarlo, Daniele ^a   Paris, Francesco ^a   Cascavilla, Leandro ^a   Urbano, Maria ^a   Gravina, Carolina ^a   Fontana, Andrea ^a   Solfrizzi, Vincenzo ^b   Pellegrini, Fabio ^a,c   Pilotto, Alberto ^a  

^a CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

^b UNIVERSITY OF BARI   (Italy)

^c IRCCS 'Casa Sollievo della Sofferenza' ^*  (Italy)

Author keywords

Alzheimer's disease; APOE; apolipoprotein E; dementia; neuropsychiatric symptoms; neuropsychiatric syndromes

Indexed keywords

APOLIPOPROTEIN E2; APOLIPOPROTEIN E3; APOLIPOPROTEIN E4;

ADL DISABILITY; AGED; ALZHEIMER DISEASE; APATHY; ARTICLE; COGNITIVE DEFECT; COMORBIDITY; CONTROLLED STUDY; DEMENTIA; DISEASE CLASSIFICATION; EMOTIONAL DISORDER; ENDOPHENOTYPE; FEMALE; GENETIC ANALYSIS; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; GERIATRIC ASSESSMENT; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; HYPERACTIVITY; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MOOD DISORDER; NEUROLOGIC DISEASE; NEUROPSYCHIATRIC INVENTORY; PSYCHOLOGIC ASSESSMENT; PSYCHOSIS; SYMPTOMATOLOGY;

ACTIVITIES OF DAILY LIVING; AGED; AGED, 80 AND OVER; ALLELES; ALZHEIMER DISEASE; APOLIPOPROTEINS E; COGNITION DISORDERS; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; ODDS RATIO; POLYMORPHISM, GENETIC; PSYCHIATRIC STATUS RATING SCALES; RISK FACTORS;

EID: 80052761443     PISSN: 08856230     EISSN: 10991166     Source Type: Journal    
DOI: 10.1002/gps.2644     Document Type: Article

References (71)

1. Aalten P, Verhey FR, Boziki M, et al,. 2007. Neuropsychiatric syndromes in dementia. Results from the European Alzheimer Disease Consortium: part I. Dement Geriatr Cogn Disord 24: 457-463. (Pubitemid 350175906)
2. Aalten P, Verhey FR, Boziki M, et al,. 2008. Consistency of neuropsychiatric syndromes across dementias: results from the European Alzheimer Disease Consortium: part II. Dement Geriatr Cogn Disord 25: 1-8. (Pubitemid 350308380)
3. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th edn. American Psychiatric Association: Washington; 1994.
4. Ballard C, Massey H, Lamb H, Morris C,. 1997. Apolipoprotein E: non-cognitive symptoms and cognitive decline in late onset Alzheimer's disease. J Neurol Neurosurg Psychiatry 63: 273.
5. Bliss MR, McLaren R, Exton-Smith AN,. 1966. Mattresses for preventing pressure sores in geriatric patients. Mon Bull Minist Health Public Health Lab Serv 25: 238-268.
6. Borroni B, Grassi M, Agosti C, et al,. 2006. Genetic correlates of behavioral endophenotypes in Alzheimer disease: role of COMT, 5-HTTLPR and APOE polymorphisms. Neurobiol Aging 27: 1595-1603. (Pubitemid 44363107)
7. Cantillon M, Harwood D, Barker W, et al,. 1997. No association between apolipoprotein E genotype and late-onset depression in Alzheimer's disease. Biol Psychiatry 41: 246-248. (Pubitemid 27062670)
8. Chan DC, Kasper JD, Black BS, Rabins PV,. 2003. Prevalence and correlates of behavioral and psychiatric symptoms in community-dwelling elders with dementia or mild cognitive impairment: The Memory and Medical Care Study. Int J Geriatr Psychiatry 18: 174-182. (Pubitemid 36236242)
9. Chang JB, Wang PN, Chen WT, et al,. 2004. ApoE epsilon4 allele is associated with incidental hallucinations and delusions in patients with AD. Neurology 63: 1105-1107. (Pubitemid 39287928)
10. Ciampi A, Negassa A, Lou Z,. 1995. Tree-structured prediction for censored survival data and the Cox model. J Clin Epidemiol 48: 675-689.
11. Craig AH, Cummings JL, Fairbanks L, et al,. 1996. Cerebral blood flow correlates of apathy in Alzheimer disease. Arch Neurol 53: 1116-1120. (Pubitemid 26380292)
12. Craig D, Hart DJ, McCool K, McIlroy SP, Passmore AP,. 2004. Apolipoprotein E ∈4 allele influences aggressive behaviour in Alzheimer's disease. J Neurol Neurosurg Psychiatry 75: 1327-1330. (Pubitemid 39141343)
13. Craig D, Hart DJ, McIlroy SP, Passmore AP,. 2005. Association analysis of apolipoprotein E genotype and risk of depressive symptoms in Alzheimer's disease. Dement Geriatr Cogn Disord 19: 154-157. (Pubitemid 40868043)
14. Cummings JL,. 2000. Cognitive and behavioral heterogeneity in Alzheimer's disease: seeking the neurobiological basis. Neurobiol Aging 21: 845-861.
15. Cummings JL, Mega M, Gray K, et al,. 1994. The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology 44: 2308-2314. (Pubitemid 24382728)
16. D'Ath P, Katona P, Mullan E, Evans S, Katona C,. 1994. Screening, detection and management of depression in elderly primary care attenders. I: The acceptability and performance of the 15 item Geriatric Depression Scale (GDS15) and the development of short versions. Fam Pract 11: 260-266. (Pubitemid 24309682)
17. De Berardis G, Pellegrini F, Franciosi M, et al,. 2007. Clinical and psychological predictors of incidence of self-reported erectile dysfunction in patients with type 2 diabetes. J Urol 177: 252-257. (Pubitemid 44895328)
18. Delano-Wood L, Houston WS, Emond JA, et al,. 2008. APOE genotype predicts depression in women with Alzheimer's disease: a retrospective study. Int J Geriatr Psychiatry 23: 632-636. (Pubitemid 351943849)
19. de Leeuw FE, Richard F, de Groot JC, et al,. 2004. Interaction between hypertension, apoE, and cerebral white matter lesions. Stroke 35: 1057-1060. (Pubitemid 38543516)
20. Finkel SI, Costa e, Silva J, et al,. 1996. Behavioral and psychological signs and symptoms of dementia: a consensus statement on current knowledge and implications for research and treatment. Int Psychogeriatr 8: 497-500. (Pubitemid 27229556)
21. Folstein M, Folstein S, McHugh PR,. 1975. Mini-mental state: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12: 189-198.
22. Forsell Y, Basun H, Corder EH, et al,. 1998. Psychotic symptoms and apolipoprotein E genotypes in an elderly population. Biol Psychiatry 144: 139-140. (Pubitemid 28305533)
23. Forsell Y, Corder EH, Basun H, et al,. 1997. Depression and dementia in relation to apolipoprotein E polymorphism in a population sample age 75+. Biol Psychiatry 42: 898-903. (Pubitemid 27486443)
24. Gabryelewicz T, Religa D, Styczynska M, et al,. 2002. Behavioural pathology in Alzheimer's disease with special reference to apolipoprotein E genotype. Dement Geriatr Cogn Disord 14: 208-212. (Pubitemid 36151488)
25. Gerdes LU, Klausen IB, Sihm I, Fargeman O,. 1992. Apolipoprotein E polymorphism in a Danish population compared to findings in 45 other study populations around the world. Genet Epidemiol 9: 155-167.
26. Hachinski VC, Iliff LD, Zilhka E, et al,. 1975. Cerebral blood flow in dementia. Arch Neurol 32: 632-637.
27. Harwood DG, Barker WW, Ownby RL, et al,. 1999. Apolipoprotein-E (APO-E) genotype and symptoms of psychosis in Alzheimer's disease. Am J Geriatr Psychiatry 7: 119-123. (Pubitemid 29165460)
28. Hermann N, Lanctot KL, Sambrook R, et al,. 2006. The contribution of neuropsychiatric symptoms to the cost of dementia care. Int J Geriat Psychiatry 21: 972-976. (Pubitemid 44596392)
29. Hirono N, Mori E, Yasuda M, et al,. 1998. Factors associated with psychotic symptoms in Alzheimer's disease. J Neurol Neurosurg Psychiatry 64: 648-652. (Pubitemid 28204153)
30. Hirono N, Mori E, Yasuda M, et al,. 1999. Lack of effect of apolipoprotein E E4 allele on neuropsychiatric manifestations in Alzheimer's disease. J Neuropsychiatry Clin Neurosci 11: 66-70. (Pubitemid 29070666)
31. Hollingworth P, Hamshere ML, Moskvina V, et al,. 2006. Four components describe behavioral symptoms in 1,120 individuals with late-onset Alzheimer's disease. J Am Geriatr Soc 54: 1348-1354. (Pubitemid 44342883)
32. Holmes C, Levy R, McLoughlin DM, Powell JF, Lovestone S,. 1996. Apolipoprotein E: non-cognitive symptoms and cognitive decline in late onset Alzheimer's disease. J Neurol Neurosurg Psychiatry 61: 580-583. (Pubitemid 27023334)
33. Holmes C, McLoughlin DM, Powell J, Lovestone S,. 1997. Reply. J Neurol Neurosurg Psychiatry 63: 273-374.
34. Holmes C, Russ C, Kirov G, et al,. 1998. Apolipoprotein E: depressive illness, depressive symptoms and Alzheimer's disease. Biol Psychiatry 43: 159-164. (Pubitemid 28096552)
35. Hughes CP, Berg L, Danziger WL, Coben LA, Martin RL,. 1982. A new clinical scale for the staging of dementia. Br J Psychiatry 140: 566-572. (Pubitemid 12124384)
36. Katz S, Akpom CA,. 1976. A measure of primary sociobiological functions. Int J Health Serv 6: 493-507.
37. Lavretsky H, Lesser IM, Wohl M, et al,. 2000. Apolipoprotein-E and white-matter hyperintensities in late-life depression. Am J Geriatric Psychiatry 8: 257-261. (Pubitemid 30457573)
38. Lawton MP, Brody EM,. 1996. Assessment of older people: self maintaining and instrumental activities of daily living. Gerontologist 9: 179-186.
39. Lehtovirta M, Soininen H, Helisalmi S, et al,. 1996. Clinical and neuropsychological characteristics in familial and sporadic Alzheimer's disease: relation to apolipoprotein E polymorphism. Neurology 46: 413-419. (Pubitemid 26081323)
40. Levy ML, Cummings JL, Fairbanks LA, Sultzer DL, Small GW,. 1999. Apolipoprotein E genotype and noncognitive symptoms in Alzheimer's disease. Biol Psychiatry 45: 422-425. (Pubitemid 29130439)
41. Lopez OL, Kamboh MI, Becker JT, Kaufer DI, Dekosky ST,. 1997. The apolipoprotein E epsilon 4 allele is not associated with psychotic symptoms or extrapyramidal signs in probable Alzheimer's disease. Neurology 49: 794-797. (Pubitemid 27428024)
42. Lyketsos CG, Baker L, Warren A, et al,. 1997. Depression, delusions and hallucinations in Alzheimer's disease: no relationship to apolipoprotein E genotype. J Neuropsychiatry Clin Neurosci 9: 64-67. (Pubitemid 27075415)
43. Lyketsos CG, Lopez O, Jones B, et al,., DeKosky S,. 2002. Prevalence of neuropsychiatric symptoms in dementia and mild cognitive impairment: results from the cardiovascular health study. JAMA 288: 1475-1483.
44. McCarron MO, Delong D, Alberts MJ,. 1999. APOE genotype as a risk factor for ischemic cerebrovascular disease. Neurology 53: 1308-1311. (Pubitemid 29480092)
45. McKhann G, Drachman D, Folstein M, et al,. 1984. Clinical diagnosis of Alzheimer Disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Service Task Force on Alzheimer's Disease. Neurology 34: 939-944. (Pubitemid 14076461)
46. Mega MS, Cummings JL, Fiorello T, Gornbein J,. 1996. The spectrum of behavioral changes in Alzheimer's disease. Neurology 46: 130-135. (Pubitemid 26156117)
47. Miller SA, Dykes DD, Polesky HF,. 1988. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16: 1215.
48. Monastero R, Mariani E, Camarda C, et al,. 2006. Association between apolipoprotein E epsilon4 allele and apathy in probable Alzheimer's disease. Acta Psychiatr Scand 113: 59-5963.
49. Morris JC,. 1993. The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology 43: 2412-2414. (Pubitemid 23346995)
50. Murman DL, Chen Q, Powell MC, et al,. 2002. The incremental direct costs associated with behavioral symptoms in AD. Neurology 59: 1721-1729. (Pubitemid 35424453)
51. O'Brien J, Perry R, Barber R, Gholkar A, Thomas A,. 2000. The association between white matter lesions on magnetic resonance imaging and noncognitive symptoms. Ann N Y Acad Sci 903: 482-489. (Pubitemid 30251593)
52. Parmalee PA, Thuras PD, Katz IR, Lawton MP,. 1995. Validation of the Cumulative Illness Rating Scale in a geriatric residential population. J Am Geriatr Soc 43: 130-137.
53. Pritchard AL, Harris J, Pritchard CW, et al,. 2007. The effect of the apolipoprotein E gene polymorphisms and haplotypes on behavioural and psychological symptoms in probable Alzheimer's disease. J Neurol Neurosurg Psychiatry 78: 123-126. (Pubitemid 46220206)
54. Ramachandran G, Marder K, Tang M, et al,. 1996. A preliminary study of apolipoprotein E genotype and psychiatric manifestations of Alzheimer's disease. Neurology 47: 256-259. (Pubitemid 26243894)
55. Reisberg B, Auer SR, Monteiro IM,. 1996. Behavioral pathology in Alzheimer's Disease (BEHAVE-AD) Rating Scale. Int Psychogeriat 8: 301-308. (Pubitemid 27229522)
56. Robertson J, Curley J, Kaye J, et al,. 2005. APOE isoforms and measures of anxiety in probable AD patients and apoe-/-mice. Neurobiol Aging 26: 637-643. (Pubitemid 40228755)
57. Román GC, Tatemichi TK, Erkinjuntti T, et al,. 1993. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 43: 250-260. (Pubitemid 23060253)
58. Scarmeas N, Brandt J, Albert M, et al,. 2002. Association between the APOE genotype and psychopathologic symptoms in Alzheimer's disease. Neurology 58: 1182-1188. (Pubitemid 34411861)
59. Seripa D, Signori E, Gravina C, et al,. 2006. Simple and effective determination of apolipoprotein E genotypes by positive/negative polymerase chain reaction products. Diagn Mol Pathol 15: 180-185. (Pubitemid 44325481)
60. Shinosaki K, Nishikawa T, Takeda M,. 2000. Neurobiological basis of behavioral and psychological symptoms in dementia of the Alzheimer type. Psychiatry Clin Neurosci 54: 611-620. (Pubitemid 32007066)
61. Soininen H, Kosunen O, Helisalmi S, et al,. 1995. A severe loss of choline acetyltransferase in the frontal cortex of Alzheimer patients carrying apolipoprotein epsilon 4 allele. Neurosci Lett 187: 79-82.
62. Spalletta G, Bernardini S, Bellincampi L, Federici G, Trequattrini A, Caltagirone C,. 2006. Delusion symptoms are associated with APOE ∈4 allelic variant at the early stage of Alzheimer's disease with late onset. Eur J Neurol 13: 176-182.
63. Steele C, Rovner B, Chase GA, Folstein M,. 1990. Psychiatric symptoms and nursing home placement of patients with Alzheimer's disease. Am J Psychiatry 147: 1049-1051. (Pubitemid 20257519)
64. Steinberg M, Corcoran C, Tschanz JT, et al,. 2006. Risk factors for neuropsychiatric symptoms in dementia: the Cache County Study. Int J Geriatr Psychiatry 21: 824-830. (Pubitemid 44492554)
65. Tran P, Schmidt K, Gallo J, et al,. 2006. Neuropsychiatric symptoms and medical illness in patients with dementia: an exploratory study. J Am Osteopath Assoc 106: 412-414. (Pubitemid 44259821)
66. Treiber KA, Lyketsos CG, Corcoran C, et al,. 2008. Vascular factors and risk for neuropsychiatric symptoms in Alzheimer's disease: the Cache County Study. Int Psychogeriatr 20: 538-553. (Pubitemid 351465551)
67. van der Flier WM, Staekenborg S, Pijnenburg YA, et al,. 2007. Apolipoprotein E genotype influences presence and severity of delusions and aggressive behavior in Alzheimer disease. Dement Geriatr Cogn Disord 23: 42-46. (Pubitemid 46005790)
68. Vellas B, Guigoz Y, Garry PJ, et al,. 1999. The Mini Nutritional Assessment (MNA) and its use in grading the nutritional state of elderly patients. Nutrition 15; 116-122. (Pubitemid 29072654)
69. Weiner MF, Vega G, Risser RC, et al,. 1999. Apolipoprotein E epsilon 4, other risk factors, and course of Alzheimer's disease. Biol Psychiatry 45: 633-638. (Pubitemid 29147373)
70. Yamaguchi H, Sugihara S, Ogawa A, Oshima N, Ihara Y,. 2001. Alzheimer beta amyloid deposition enhanced by apoE epsilon4 gene precedes neurofibrillary pathology in the frontal association cortex of nondemented senior subjects. J Neuropathol Exp Neurol 60: 731-739. (Pubitemid 32619796)
71. Yesavage JA, Brink TL, Rose TL, et al,. 1982-1983. Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatr Res 17; 37-49.